Polaris Capital Management LLC maintained its stake in shares of Natus Medical Incorporated (NASDAQ:BABY) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 66,220 shares of the medical equipment provider’s stock at the end of the second quarter. Polaris Capital Management LLC owned 0.20% of Natus Medical worth $2,470,000 as of its most recent SEC filing.
A number of other large investors also recently made changes to their positions in BABY. Riverhead Capital Management LLC raised its position in shares of Natus Medical by 90.9% in the 2nd quarter. Riverhead Capital Management LLC now owns 2,864 shares of the medical equipment provider’s stock worth $107,000 after acquiring an additional 1,364 shares in the last quarter. Ameritas Investment Partners Inc. bought a new position in shares of Natus Medical in the 1st quarter worth about $110,000. Sei Investments Co. raised its position in shares of Natus Medical by 29.7% in the 2nd quarter. Sei Investments Co. now owns 3,182 shares of the medical equipment provider’s stock worth $119,000 after acquiring an additional 728 shares in the last quarter. Victory Capital Management Inc. raised its position in shares of Natus Medical by 94.0% in the 1st quarter. Victory Capital Management Inc. now owns 3,184 shares of the medical equipment provider’s stock worth $125,000 after acquiring an additional 1,543 shares in the last quarter. Finally, Flinton Capital Management LLC raised its position in shares of Natus Medical by 82.0% in the 2nd quarter. Flinton Capital Management LLC now owns 3,774 shares of the medical equipment provider’s stock worth $141,000 after acquiring an additional 1,700 shares in the last quarter. 92.66% of the stock is owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY NOTICE: This news story was reported by Markets Daily and is owned by of Markets Daily. If you are viewing this news story on another domain, it was copied illegally and republished in violation of international copyright and trademark legislation. The legal version of this news story can be read at https://www.themarketsdaily.com/2017/10/13/polaris-capital-management-llc-has-2470000-position-in-natus-medical-incorporated-baby.html.
In related news, Director Robert A. Gunst sold 4,400 shares of the stock in a transaction dated Thursday, September 14th. The shares were sold at an average price of $35.17, for a total value of $154,748.00. Following the completion of the transaction, the director now directly owns 50,850 shares of the company’s stock, valued at $1,788,394.50. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director William M. Moore sold 3,000 shares of the stock in a transaction dated Monday, August 14th. The stock was sold at an average price of $34.10, for a total transaction of $102,300.00. Following the completion of the transaction, the director now directly owns 30,410 shares of the company’s stock, valued at $1,036,981. The disclosure for this sale can be found here. 5.50% of the stock is owned by corporate insiders.
BABY has been the subject of several research analyst reports. Zacks Investment Research lowered Natus Medical from a “hold” rating to a “sell” rating in a research report on Friday, July 28th. BidaskClub raised Natus Medical from a “sell” rating to a “hold” rating in a research report on Saturday, July 1st. Two analysts have rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $48.00.
Natus Medical Incorporated (NASDAQ:BABY) traded up 0.062% on Friday, hitting $40.225. The stock had a trading volume of 61,465 shares. Natus Medical Incorporated has a 52-week low of $31.65 and a 52-week high of $43.85. The stock’s 50-day moving average is $35.99 and its 200-day moving average is $36.08. The company has a market cap of $1.31 billion, a P/E ratio of 69.714 and a beta of 0.95.
Natus Medical (NASDAQ:BABY) last released its quarterly earnings results on Wednesday, July 26th. The medical equipment provider reported $0.34 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.33 by $0.01. Natus Medical had a net margin of 4.20% and a return on equity of 12.09%. The company had revenue of $122.20 million during the quarter, compared to the consensus estimate of $121.99 million. During the same period in the prior year, the firm earned $0.39 earnings per share. Natus Medical’s revenue was up 27.3% on a year-over-year basis. Analysts expect that Natus Medical Incorporated will post $1.70 earnings per share for the current year.
Natus Medical Company Profile
Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.
Receive News & Ratings for Natus Medical Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.